Perceive Biotherapeutics
South San Francisco, US · Founded 2020 · Delaware corporation · 1 known investors
Founders & leadership
WD
Watson DebiNamed on SEC filing
AR
Anne RubinNamed on SEC filing
KA
Kirsten Angela MacfarlaneNamed on SEC filing
CW
Cameron WheelerNamed on SEC filing
RO
Randall OlsonNamed on SEC filing
RJ
Robert JacksonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$40M disclosed across 1 round · 2022
▶$40MraisedJan 2023 · 6 investors · BiotechnologyRule 506(b)
▶$40MraisedJan 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Watson DebiDirector
- Anne RubinExecutive Officer, Director
- Kirsten Angela MacfarlaneExecutive Officer, Director, Promoter
- Cameron WheelerDirector
- Randall OlsonDirector
- Robert JacksonDirector
- Offering amount
- $78M
- Amount sold
- $40M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Perceive Biotherapeutics's investors?
- Perceive Biotherapeutics's investors include Catalio Capital Management, LP.
- How much funding has Perceive Biotherapeutics raised?
- Perceive Biotherapeutics has disclosed $40M raised across 1 round.
- Where is Perceive Biotherapeutics headquartered?
- Perceive Biotherapeutics is headquartered in South San Francisco, US.